What the research found

Researchers analysed cardiovascular health data from over 300,000 middle-aged and older adults in the UK Biobank, stratifying participants by their self-identified sleep-wake preferences. Those who described themselves as "evening people" (roughly 8% of the cohort) reported significantly worse scores on the American Heart Association's Life's Essential 8 framework—a composite measure spanning diet, physical activity, smoking status, sleep quality, body weight, cholesterol, blood glucose, and blood pressure. Over a median 14-year follow-up, evening chronotypes showed a 16% elevated risk of cardiovascular events (heart attack or stroke) compared to intermediate types.

The excess risk appeared partly attributable to behavioural clustering: night owls were more likely to smoke and report insufficient sleep. Interestingly, the cardiovascular disadvantage was more pronounced in women than men. Conversely, self-identified "morning people" (24% of participants) showed a 5% lower prevalence of poor cardiovascular health scores relative to the intermediate group.

Why it matters for you

If you track sleep as part of your health protocol, this signals that chronotype mismatch—being forced to operate against your natural rhythm—may compound cardiovascular stress beyond simple sleep duration. The study suggests that a night owl pushing early wake times without addressing underlying circadian misalignment might accumulate unfavourable shifts in multiple biomarkers you monitor: blood pressure, fasting glucose, lipid panel, and resting heart rate. The mechanism isn't circadian biology alone; rather, evening types appear more vulnerable to lifestyle drift (smoking, irregular eating, fragmented sleep), which cascades across your tracked metrics.

For protocol design, the authors flag that chronotype should inform when you schedule interventions. If you're optimising TRT dosing, supplement timing, or training windows, aligning these with your natural activity peaks rather than fighting your chronotype may improve adherence and metabolic response. Similarly, if you're an evening chronotype, the data suggest targeting smoking cessation and sleep consistency as particularly high-leverage moves for your cardiovascular risk profile.

Caveats

• Observational and cross-sectional chronotype assessment: Chronotype was self-reported once, not measured objectively (e.g. via actigraphy or repeated questionnaires), and causality cannot be established from observational data.
• Population homogeneity: Participants were predominantly white, healthier than the general population, and UK-based; findings may not generalise to other ethnic groups or healthcare systems.
• Confounding by behaviour, not biology alone: Much of the excess risk was explained by smoking and poor sleep, raising the question of whether evening chronotype itself is aetiological or a marker of populations with different health behaviours.
• Partially industry-funded: The study received American Heart Association support, which may influence messaging (though the journal is peer-reviewed and open-access).